Cerevel Therapeutics Fitout, 222 Jacobs Street
Description: The biopharmaceutical company Cerevel Therapeutics is moving into Cambridge Crossing, joining Philips North America at 222 Jacobs St. in Cambridge, Massachusetts. The company signed a 59,865-square-foot lease with DivcoWest, making the third commercial building at the complex (222 Jacobs St.) fully leased.
Scope of Work: Fenagh observed concrete placement and performed sampling for the Interior Floor. We monitored loads for mix no., slump, temperature, and discharge time. Fenagh prepared cylinder test specimens from point of discharge and subsequently performed laboratory testing. Learn more about Fenagh’s services here.